5-HT2C receptor modulation and the treatment of obesity

被引：36
|
作者：
Bickerdike, MJ [1 ]
Vickers, SP [1 ]
Dourish, CT [1 ]
机构：
[1] Cerebrus PLC, Wokingham RG41 5UA, England
来源：
DIABETES OBESITY & METABOLISM | 1999年 / 1卷 / 04期
关键词：
D O I：
10.1046/j.1463-1326.1999.00037.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：207 / 214
页数：8
相关论文
共 50 条
  • [41] Indolines as 5-HT2C receptor ligands.
    Pratt, RM
    Adams, DR
    Bebbington, D
    Bentley, JM
    Benwell, K
    Bickerdike, MJ
    Cliffe, IA
    Davidson, JEP
    Dawson, CE
    Duncton, MAJ
    Gaur, S
    George, AR
    Giles, PR
    Hamlyn, RJ
    Kennett, GA
    Knight, T
    Malcolm, C
    Mansell, HL
    Misra, A
    Monck, NJT
    Roffey, JR
    Vickers, S
    Dourish, CT
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U67 - U67
  • [42] Comparative modulation of hippocampal 5-HT release by the 5-HT2C receptor antagonist SB 206553 and paroxetine
    Thorn, L
    Routledge, C
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 : P257 - P257
  • [43] Activating mutations of the serotonin 5-HT2C receptor
    HerrickDavis, K
    Egan, C
    Teitler, M
    JOURNAL OF NEUROCHEMISTRY, 1997, 69 (03) : 1138 - 1144
  • [44] Allelic variation in the 5-HT2C receptor (HTR2C) and functional responses to the 5-HT2C receptor agonist, m-chlorophenylpiperazine
    D. J. Quested
    R. Whale
    A. L. Sharpley
    C. L. McGavin
    N. Crossland
    P. J. Harrison
    P. J. Cowen
    Psychopharmacology, 1999, 144 : 306 - 307
  • [45] Modeling tardive dyskinesia: Predictive 5-HT2C receptor antagonist treatment
    Richard M. Kostrzewa
    Nuo-Yu Huang
    John P. Kostrzewa
    Przemyslaw Nowak
    Ryszard Brus
    Neurotoxicity Research, 2007, 11 : 41 - 50
  • [46] Roles of the 5-HT2C receptor on zebrafish sociality
    Moura, Layana Aquino de
    Pyterson, Maryana Pereira
    Pimentel, Ana Flavia Nogueira
    Araujo, Fernanda
    Souza, Loanne Valeria Xavier Bruce de
    Mendes, Caio Henrique Moura
    Costa, Bruna Patricia Dutra
    Siqueira-Silva, Diogenes Henrique de
    Maximino, Monica Lima-
    Maximino, Caio
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2023, 125
  • [47] Therapeutic Potential of 5-HT2C Receptor Ligands
    Jensen, Nanna H.
    Cremers, Thomas I.
    Sotty, Florence
    THESCIENTIFICWORLDJOURNAL, 2010, 10 : 1870 - 1885
  • [48] 5-HT2C receptor antagonists:: Potential in schizophrenia
    Wood, MD
    Heidbreder, C
    Reavill, C
    Ashby, CR
    Middlemiss, DN
    DRUG DEVELOPMENT RESEARCH, 2001, 54 (02) : 88 - 94
  • [49] Indoline derivatives as 5-HT2C receptor agonists
    Bentley, JM
    Adams, DR
    Bebbington, D
    Benwell, KR
    Bickerdike, MJ
    Davidson, JEP
    Dawson, CE
    Dourish, CT
    Duncton, MAJ
    Gaur, S
    George, AR
    Giles, PR
    Hamlyn, RJ
    Kennett, GA
    Knight, AR
    Malcolm, CS
    Mansell, HL
    Misra, A
    Monck, NJT
    Pratt, RM
    Quirk, K
    Roffey, JRA
    Vickers, SP
    Cliffe, IA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (09) : 2367 - 2370
  • [50] Allelic variation of the 5-HT2C receptor in psychosis
    Sodhi, MS
    Kirov, G
    Aitchison, KJ
    Arranz, MJ
    Collier, DA
    Kerwin, RW
    SCHIZOPHRENIA RESEARCH, 1997, 24 (1-2) : 90 - 91
12345